Post-exposure prophylaxis (PEP) is the standard of care for occupational exposure to HIV
infection although it has not been evaluated following non-occupational exposure. Although …

1.1 Background Since the early 1990s, in many countries antiretroviral medicines have been
prescribed for postexposure prophylaxis (PEP) following occupational exposure to the …

Guidelines for antiretroviral (ARV) prophylaxis following high-risk exposure (postexposure
prophylaxis—PEP) to human immunodeficiency virus (HIV) date to 1990, when the US …

Data supporting the efficacy of HIV postexposure prophylaxis (PEP) come largely from a
small number of older studies and case reports in health care workers, studies of …

There is no solid evidence for the efficacy of HIV post-exposure prophylaxis (PEP). However,
animal studies, data from mother-to-child transmission studies and one retrospective case …

BACKGROUND AND OBJECTIVE: Although occupational post-exposure HIV prophylaxis is
widely admitted and used, the non-occupational post-exposure prophylaxis (NONOPEP) is …

Background During recent years, the use of antiretroviral therapy expanded beyond the
treatment of HIV-infected patients. Since the outset of the HIV epidemic, antiretroviral drugs …

Although human immunodeficiency virus (HIV) incidence in the United States was relatively
stable from 2006 to 2009, a total of 48,100 new HIV infections were estimated to have …

Postexposure prophylaxis (PEP) with antiretroviral medication has been used as an HIV-
prevention strategy for nearly 20 years. The fact that approximately 50 000 new HIV …

Post-exposure prophylaxis (PEP) in the form of combination drug therapy is now
recommended for healthcare workers following occupational HIV exposure. The expansion …